Correlation of Professional Antigen-Presenting Tbet+CD11c+ B Cells With Bone Destruction in Untreated Rheumatoid ArthritisShow others and affiliations
2024 (English)In: Arthritis & Rheumatology, ISSN 2326-5191, E-ISSN 2326-5205, Vol. 76, no 8, p. 1263-1277Article in journal (Refereed) Published
Abstract [en]
Objective: Subsets of CD21−/low memory B cells (MBCs), including double-negative (DN, CD27−IgD−) and Tbet+CD11c+ cells, are expanded in chronic inflammatory diseases. In rheumatoid arthritis (RA), CD21−/low MBCs correlate with joint destruction. However, whether this is due to the Tbet+CD11c+ subset, its function and pathogenic contribution to RA are unknown. This study aims to investigate the association between CD21−/lowTbet+CD11c+ MBCs and joint destruction as well as other clinical parameters and to elucidate their functional properties in patients with untreated RA (uRA). Methods: Clinical observations were combined with flow cytometry (n = 36) and single-cell RNA sequencing (scRNA-seq) and V(D)J sequencing (n = 4) of peripheral blood (PB) MBCs from patients with uRA. The transcriptome of circulating Tbet+CD11c+ MBCs was compared with scRNA-seq data of synovial B cells. In vitro coculture of Tbet+CD11c+ B cells with T cells was used to assess costimulatory capacity. Results: CD21−/lowTbet+CD11c+ MBCs in PB correlated with bone destruction but no other clinical parameters analyzed. The Tbet+CD11c+ MBCs have undergone clonal expansion and express somatically mutated V genes. Gene expression analysis of these cells identified a unique signature of more than 150 up-regulated genes associated with antigen presentation functions, including B cell receptor activation and clathrin-mediated antigen internalization; regulation of actin filaments, endosomes, and lysosomes; antigen processing, loading, presentation, and costimulation; a transcriptome mirrored in their synovial tissue counterparts. In vitro, Tbet+CD11c+ B cells induced retinoic acid receptor–related orphan nuclear receptor γT expression in CD4+ T cells, thereby polarizing to Th17 cells, a T cell subset critical for osteoclastogenesis and associated with bone destruction. Conclusion: This study suggests that Tbet+CD11c+ MBCs contribute to the pathogenesis of RA by promoting bone destruction through antigen presentation, T cell activation, and Th17 polarization. (Figure presented.).
Place, publisher, year, edition, pages
John Wiley & Sons, 2024. Vol. 76, no 8, p. 1263-1277
National Category
Immunology in the medical area Clinical Medicine Cell and Molecular Biology
Research subject
Infection Biology
Identifiers
URN: urn:nbn:se:his:diva-23888DOI: 10.1002/art.42857ISI: 001228295000001PubMedID: 38570939Scopus ID: 2-s2.0-85193702753OAI: oai:DiVA.org:his-23888DiVA, id: diva2:1862874
Funder
Swedish Research Council, 2020-06193Swedish Research Council, 2016-01576Swedish Research Council, 2018-03128Swedish Research Council, 2021-01150Swedish Rheumatism Association, R-982095Swedish Rheumatism Association, R-94129Swedish Cancer Society, 19-0464Swedish Cancer Society, 22-2467PjIngaBritt and Arne Lundberg’s Research Foundation, LU2020-0061IngaBritt and Arne Lundberg’s Research Foundation, LU2015-093IngaBritt and Arne Lundberg’s Research Foundation, LU2019-0031Foundation for Assistance to Disabled People in SkaneTornspiran FoundationWilhelm och Martina Lundgrens Vetenskapsfond
Note
CC BY-NC-ND 4.0 DEED
© 2024 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
Correspondence Address: I.-L. Mårtensson; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; email: lill.martensson@rheuma.gu.se
Supported by the Swedish Research Council (grants 2020-06193 to Dr Ekwall, 2016-01576 to Dr Gjertsson, and 2018-03128 and 2021-01150 to Dr Mårtensson); Patient Association for Rheumatic Diseases (grants R-982095 to Dr Gjertsson and R-94129 to Dr Mårtensson); King Gustav V Stiftelse (grant FAI-2022-0876 to Dr Gjertsson); The Swedish Cancer Foundation (grants 19-0464 and 22-2467Pj to Dr Mårtensson); ALF (agreement; the Swedish government and the county council) (grants ALFGBG-926321 to Dr Ekwall, ALFGBG-719631 to Dr Gjertsson, and ALFGBG-277797 to Dr Mårtensson); and IngaBritt och Arne Lundbergs Foundation (grants LU2020-0061 to Dr Gjertsson and LU2015-093 and LU2019-0031 to Dr Mårtensson). Dr McGrath’s work was supported by The Foundation for assistance to disabled people in Skane (“Stiftelsen för bistånd åt Rörelsehindrade i Skåne”), Tornspiran Foundation, Mary von Sydows Foundation, and Wilhelm and Martina Lundgrens Foundation.
2024-05-302024-05-302025-02-18Bibliographically approved